PFKFB3 and type 1 diabetes mellitus: This work demonstrates that the rate- limiting glycolysis enzyme PFKFB3 is a novel target for controlling autoreactive T cell activation as a means to protect against the onset of T1D by enforcing exhaustion of pathogenic T cells.